Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Manchester BIOGEL

Manchester BIOGEL
2014 FOUNDED
PRIVATE STATUS
1-10 EMPLOYEES
Early Stage VC LATEST DEAL TYPE
$2.9M LATEST DEAL AMOUNT
4 INVESTORS
Description

Developer of peptide-based hydrogels technology intended to improve cell culture. The company's technology offers a family of high-quality peptide hydrogels, with a range of mechanical and functional properties to open up exciting new opportunities within the fields of 3D cell culture, 3D bioprinting, regenerative medicine and medical devices, enabling doctors to solve current healthcare challenges and find the suitable materials for their application needs.

Formerly Known As
PeptiGelDesign
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Other Healthcare Technology Systems
Primary Office
  • 19F4 Mereside, Alderley Park
  • Alderley Edge
  • Cheshire SK10 4TG
  • England, United Kingdom

+44 01625 000000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Manchester BIOGEL’s full profile, request a free trial.

Manchester BIOGEL Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Early Stage VC 05-Apr-2019 $2.9M 00.000 00.000 Completed Generating Revenue
4. Early Stage VC 01-Nov-2017 00000 00.000 00.000 Completed Generating Revenue
3. Grant 12-Dec-2016 000.00 00000 Completed Startup
2. Seed Round 15-Apr-2016 $150K $150K Completed Startup
1. Angel (individual) 01-Mar-2014 Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Manchester BIOGEL Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned
Ordinary 0,000,000 00.000000 00.00 00.00 00 00.00 00.000
Ordinary 0,000,000 00.000000 00.00 00.00 00 00.00 00.000
To view this company’s complete Cap Table, request access »

Manchester BIOGEL Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Kero Venture Capital Minority 000 0000 000000 0
Horizon 2020 Government 000 0000 000000 0
Deepbridge Capital Venture Capital Minority 000 0000 000000 0
Graham Partridge Angel (individual) Minority 000 0000 000000 0

Manchester BIOGEL Executive Team (5)

Name Title Board
Seat
Contact
Info
Aline Miller Ph.D Co-Founder, Chief Executive Officer & Chief Operating Officer
Rob Winkler Chief Financial Officer
Alberto Saiani Co-Founder & Chief Scientific Officer
Guillaume Saint-Pierre Ph.D Co-Founder

1 Former Executive

You’re viewing 4 of 5 executives. Get the full list »

Manchester BIOGEL Board Members (4)

Name Representing Role Since Contact
Info
Aline Saiani Manchester BIOGEL Board Member 000 0000
Graham Partridge Manchester BIOGEL Board Member 000 0000
Roger Doo Manchester BIOGEL Chairman 000 0000
Savvas Neophytou Ph.D Deepbridge Capital Board Member 000 0000